Qube Research & Technologies LTD Biogen Inc. Put Options Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$189.07 - $236.8 $13.4 Million - $16.8 Million
-70,800 Reduced 51.98%
65,400 $12.7 Million
Q2 2024

Aug 14, 2024
BUY
$190.52 - $236.72 $22.6 Million - $28.1 Million
118,600 Added 673.86%
136,200 $31.6 Million
Q1 2024

May 14, 2024
BUY
$212.02 - $267.71 $3.73 Million - $4.71 Million
17,600 New
17,600 $3.8 Million
Q3 2023

Nov 13, 2023
BUY
$253.3 - $285.89 $4.76 Million - $5.37 Million
18,800 New
18,800 $4.83 Million

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email